FDA
approval
· 2017-01-27
FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
The FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) submitted by E.R. Squibb & Sons, L.L.C. The action involves labeling changes …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)